Similarly, systemic lupus erythematosus patients show elevated IL-9 and Th9 cells in circulation (63, 64), although IL-9 neutralization in lupus-prone mice reduces autoantibody production and renal pathology, especially when combined with IL-17 blockade (65). The gene discussed is IL17A; the disease is systemic lupus erythematosus.